Design Therapeutics, Inc. (DSGN) Tops Q4 EPS by 10c

Design Therapeutics, Inc. (NASDAQ: DSGN) reported Q4 EPS of ($0.21), $0.10 better than the analyst estimate of ($0.31).

For earnings history and earnings-related data on Design Therapeutics, Inc. (DSGN) click here.

You May Also Be Interested In

• Tesla plans 'flying' Roadster stunt at SpaceX Texas site as early as August
• Edible Garden AG (EDBL) Reports Q2 Loss of $18.79
• Star Equity Holdings (STRR) Misses Q2 EPS by 8c